+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific To Buy Intera Oncology, Maker Of Liver Cancer Treatment is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific To Buy Intera Oncology, Maker Of Liver Cancer Treatment | RobinsPost News & Noticias

Boston Sci to buy liver cancer device maker Intera Oncology - MSN


Boston Scientific (NYSE:BSX) has agreed to acquire medical device maker Intera Oncology for an undisclosed amount, with the deal expected to close in the first half of 2025. Intera’s lead ... Read More

Boston Scientific to buy Intera Oncology, maker of liver cancer treatment - Yahoo Finance


Boston Scientific to buy Intera Oncology, maker of liver cancer treatment Intera Oncology makes the Intera 3000 Hepatic Artery Infusion pump, which delivers local chemotherapy to liver tumors ... Read More

Boston Scientific to buy remaining Bolt Medical stake for up to $664M - Yahoo Finance


Boston Scientific also announced plans late last year to buy Intera Oncology, maker of a treatment for liver tumors, and Cortex, which is developing diagnostic mapping technology to detect atrial ... Read More

Boston Scientific expands infusion offerings with Intera Oncology acquisition - MSN


Boston Scientific has signed a definitive agreement to acquire a Boston-based infusion pump maker Intera Oncology. Intera’s main asset is its hepatic artery infusion (HAI) therapy device, the ... Read More

Boston Scientific picks up chemotherapy infusion implant maker aimed at inoperable liver tumors


Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable tumors in the liver, including metastatic colorectal cancer t | Intera ... Read More

Boston Scientific to acquire Intera Oncology, terms not disclosed


Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held medical device company that provides the Intera 3000 Hepatic Artery ... Read More

Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.


MARLBOROUGH, Mass., Nov. 25, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera Oncology® Inc., a ... Read More

Boston Scientific To Buy Intera Oncology For Undisclosed Terms


(RTTNews) - Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a privately held medical device company. Intera provides the ... Read More

Boston Scientific continues acquisition streak, eyes Newton cancer treatment provider


Boston Scientific is expanding its presence in cancer treatment as the Marlborough-based medical device manufacturer intends to acquire Intera Oncology, a Newton-based medical device company ... Read More

Boston Sci to buy liver cancer device maker Intera Oncology


Boston Scientific (BSX) plans to acquire medical device maker Intera Oncology for an undisclosed amount, with the deal expected to close in the first half of 2025. Read more here. Read More

Boston Scientific Corporation: Boston Scientific Announces Agreement to Acquire Intera Oncology Inc. - FinanzNachrichten.de


Acquisition to expand interventional oncology offerings with complementary therapy to treat liver-dominant metastases MARLBOROUGH, Mass., Nov. 25, 2024 /PRNewswire/ -- Boston Scientific ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus